海外の治験の状況「1」での検索結果
544件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- A Phase 1, Study Evaluating the Safety, Tolerability, PK, and Efficacy of AMG 510 in Subjects With Solid Tumors With a Specific KRAS Mutation.
- Advanced KRAS p.G12C Mutant Solid Tumors
- Australia, United States
- 2018-06-26
Recruiting
- An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
- Ulcerative Colitis
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Croatia, Czechia, Denmark, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands, Poland, Romania, Russian Federation, Serbia, Slovakia, Spain, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2018-05-04
Recruiting
- Antiphospholipid Antibodies & Osteopontin as Risk Factors for Cerebrovascular Stroke in Young Adults
- Stroke in Young Adults
- Egypt
- 2018-04-13
Recruiting
- Dose Escalation and Expansion Study of GSK3359609 in Subjects With Selected Advanced Solid Tumors (INDUCE-1)
- Cancer;Neoplasms
- Australia, Canada, France, Italy, Netherlands, Spain, United States
- 2016-03-24
Recruiting
- Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
- Non-Small Cell Lung Cancer;Malignant Melanoma;Renal Cell Cancer;Triple Negative Breast Cancer;Colorectal Cancer;Bladder Cancer;Metastatic Castration Resistant Prostate Cancer
- Australia, Canada, United States
- 2016-01-08
Recruiting
- A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors
- Locally Advanced Solid Tumors;Metastatic Solid Tumors
- Australia, Bulgaria, Germany, New Zealand, Poland, Spain, Ukraine, United Kingdom, United States
- 2017-02-09
Recruiting
- Genetic Linkage Studies of Stuttering
- Stuttering
- Central African Republic, Japan, Pakistan, United States
- 1999-11-03
Recruiting
- Follow-up of Children After Stuttering Treatment
- Stuttering
- Australia
- 2008-07-01
Recruiting
- Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP)
- Unresectable/Metastatic Melanoma
- Australia, Canada
- 2016-06-29
Recruiting
- A Phase 1 Study to Evaluate the Safety and Tolerability of AB122 in Subjects with Advanced Solid Tumors
- Advanced Solid Tumors;Endometrial cancer;Merkel cell carcinoma
- Australia
- 2017-12-18